Autonomix Medical, Inc.
AMIX
$1.39
-$0.05-3.47%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.25% | -3.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | -- | |||
| Total Operating Expenses | 18.38% | -3.14% | |||
| Operating Income | -18.38% | 3.14% | |||
| Income Before Tax | -17.66% | 3.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.66% | 3.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.66% | 3.38% | |||
| EBIT | -18.38% | 3.14% | |||
| EBITDA | -18.67% | 3.26% | |||
| EPS Basic | 20.81% | 40.66% | |||
| Normalized Basic EPS | 20.81% | 40.66% | |||
| EPS Diluted | 20.79% | 40.66% | |||
| Normalized Diluted EPS | 20.81% | 40.66% | |||
| Average Basic Shares Outstanding | 48.59% | 62.80% | |||
| Average Diluted Shares Outstanding | 48.59% | 62.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||